Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Investigating the Efficacy of Intranasal Oxytocin for Reducing Pain in Women with Chronic Pelvic Pain
EF 2016-17
Résumé
Background: Chronic pelvic pain (CPP) refers to pain in the lower abdomen or pelvis of at least six months' duration that limits one's daily activities or causes functional disability. CPP affects approximately 5.7-26.6% of women in the general population, who report poorer health and social outcomes than those without pain. The range of empirically-supported CPP treatments is limited. Oxytocin (OT) is a neuropeptide produced in hypothalamic regions of the brain. OT administration has been shown to reduce pain sensitivity among patients experiencing chronic back pain, headache, constipation, and colon pain. Importantly, the OT-pain association may be different in women with CPP due to an abundance of OT receptors in the uterus, though this has yet to be studied. Objective: The proposed study will investigate the efficacy of intranasal OT for reducing pain in women with CPP. Hypothesis: It is predicted that administration of intranasal OT will result in greater pain reduction relative to a placebo nasal spray. Method: Women with CPP will be randomized to receive either OT nasal spray or a placebo nasal spray for two weeks, followed by a 2-week wash-out period to ensure clearance of OT. Participants will then crossover for two weeks and receive the nasal spray they did not previously receive. Participants will administer the nasal sprays twice daily, once in the morning and once in the evening, and record their pain at baseline and following each 2-week period. Implications: The proposed study will contribute to the literature on treatments for chronic pain, specifically for CPP.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367110
Name
Flynn Michelle J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Efficacy of Intranasal Oxytocin for Reducing Pain in Women with Chronic Pelvic Pain
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Behavioural Medicine; Chronic Pelvic Pain; Health Psychology; Oxytocin; Randomized Clinical Trial
Abstract
Background: Chronic pelvic pain (CPP) refers to pain in the lower abdomen or pelvis of at least six months' duration that limits one's daily activities or causes functional disability. CPP affects approximately 5.7-26.6% of women in the general population, who report poorer health and social outcomes than those without pain. The range of empirically-supported CPP treatments is limited. Oxytocin (OT) is a neuropeptide produced in hypothalamic regions of the brain. OT administration has been shown to reduce pain sensitivity among patients experiencing chronic back pain, headache, constipation, and colon pain. Importantly, the OT-pain association may be different in women with CPP due to an abundance of OT receptors in the uterus, though this has yet to be studied. Objective: The proposed study will investigate the efficacy of intranasal OT for reducing pain in women with CPP. Hypothesis: It is predicted that administration of intranasal OT will result in greater pain reduction relative to a placebo nasal spray. Method: Women with CPP will be randomized to receive either OT nasal spray or a placebo nasal spray for two weeks, followed by a 2-week wash-out period to ensure clearance of OT. Participants will then crossover for two weeks and receive the nasal spray they did not previously receive. Participants will administer the nasal sprays twice daily, once in the morning and once in the evening, and record their pain at baseline and following each 2-week period. Implications: The proposed study will contribute to the literature on treatments for chronic pain, specifically for CPP.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Flynn, Michelle J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~